User:Wouter Hendrickx

From OpenWetWare
Jump to: navigation, search

I am a new member of OpenWetWare!

Contact Info

Wouter Hendrickx (an artistic interpretation)
  • Wouter Hendrickx
  • Diet and Health Group
  • Biomedical Research Centre
  • School of Medicine, Health Policy and Practice
  • University of East Anglia
  • Norwich - Norfolk
  • NR4 7TJ
  • Email me through OpenWetWare

I work in the BMRC [1] at U.E.A.. I learned about OpenWetWare from google, and I've joined because lab book use.

Education

  • 2008 - now, PhD, UEA (Norwich,UK)
  • 2002, MSC - Bioinformatics, KUL, (Leuven,Belgium)
  • 2001, MSC - Biomediacal Sciences, VUB (Brussles,Belgium)

Research interests

  1. Wound Healing
  2. Developmental Molecular Biology
  3. Cancer
  4. Stem Cells
  5. ECM modulation

Publications

  1. Wildiers H, Van Calster B, van de Poll-Franse LV, Hendrickx W, Røislien J, Smeets A, Paridaens R, Deraedt K, Leunen K, Weltens C, Van Huffel S, Christiaens MR, and Neven P. Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol. 2009 Jun 20;27(18):2931-7. DOI:10.1200/JCO.2008.16.7619 | PubMed ID:19451448 | HubMed [Paper13]
  2. Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, and Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers. 2008 Jul-Sep;23(3):161-8. PubMed ID:18949742 | HubMed [Paper12]
  3. Brouwers B, Paridaens R, Lobelle JP, Hendrickx W, Smeets A, Neven P, Weltens C, Deraedt K, Vanden Bempt I, Christiaens MR, and Wildiers H. Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancer. Tumour Biol. 2008;29(4):211-6. DOI:10.1159/000152938 | PubMed ID:18781092 | HubMed [Paper11]
  4. Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, and Neven P. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat. 2009 May;115(2):349-58. DOI:10.1007/s10549-008-0110-6 | PubMed ID:18629635 | HubMed [Paper10]
  5. Neven P, Brouckaert O, Van Belle V, Vanden Bempt I, Hendrickx W, Cho H, Deraedt K, Van Calster B, Van Huffel S, Moerman P, Amant F, Leunen K, Smeets A, Wildiers H, Paridaens R, Vergote I, and Christiaens MR. In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement. J Clin Oncol. 2008 Apr 1;26(10):1768-9; author reply 1769-71. DOI:10.1200/JCO.2007.15.6141 | PubMed ID:18519273 | HubMed [Paper09]
  6. Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, and Paridaens R. Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. BMC Cancer. 2008 Mar 20;8:77. DOI:10.1186/1471-2407-8-77 | PubMed ID:18366705 | HubMed [Paper08]
  7. Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, and Neven P. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat. 2009 Jan;113(1):181-7. DOI:10.1007/s10549-008-9914-7 | PubMed ID:18264760 | HubMed [Paper07]
  8. De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, and Neven P. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?. J Clin Oncol. 2008 Jan 10;26(2):335-6; author reply 336-8. DOI:10.1200/JCO.2007.14.8411 | PubMed ID:18182677 | HubMed [Paper06]
  9. Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, and Ye S. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res. 2007 Nov 1;67(21):10214-21. DOI:10.1158/0008-5472.CAN-07-1683 | PubMed ID:17974962 | HubMed [Paper05]
  10. Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, Van Limbergen E, Weltens C, Van den Bogaert W, Smeets A, Vergote I, Christiaens MR, and Drijkoningen M. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Res Treat. 2008 Jul;110(1):153-9. DOI:10.1007/s10549-007-9687-4 | PubMed ID:17687649 | HubMed [Paper04]
  11. Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, and Paridaens R. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas. Dis Markers. 2007;23(3):189-96. PubMed ID:17473389 | HubMed [Paper03]
  12. Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, and Ye S. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res. 2007 Nov 1;67(21):10214-21. DOI:10.1158/0008-5472.CAN-07-1683 | PubMed ID:17974962 | HubMed [Paper02]
  13. Decock J, Hendrickx W, Wildiers H, Christiaens MR, Neven P, Drijkoningen M, and Paridaens R. Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables. Clin Exp Metastasis. 2005;22(6):495-502. DOI:10.1007/s10585-005-3992-2 | PubMed ID:16320112 | HubMed [Paper01]
    leave a comment about a paper here
  14. ISBN:0879697164 [Book1]
All Medline abstracts: PubMed | HubMed

Useful links